Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex

Takashi Sakaguchi, Yuji Takamiya, Michael Edidin, Kiyoshi Nokihara, Kiyoshi Miwa, Christian Schönbach, Masafumi Takiguchi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The monoclonal antibody (mAb) 4D12 specific for the HLA-B5, -B35 cross-reacting group (CREG) bound to a fraction of HLA-B*3501 and HLA-B*5101 molecules carrying self-peptides. Analysis of the binding of mAb 4D12 to HLA-B*3501 and -B*5101 molecules pulsed with chemically synthesized peptides revealed that this mAb recognizes a restricted number of peptides and that P1 of the bound peptides critically influences its binding. The 4D12 mAb bound only to HLA-B*3501 molecules carrying peptides with Asn, Asp, Glu, Ser, and Val at P1. Analysis using an HLA-B*3501 crystallographic model suggested that 4D12 may recognize the side chain of the P1 residue that is pointing to the solvent. On the other hand, 4D12 bound only to HLA-B*51O1 molecules carrying peptides with Asn or Asp at P1, suggesting that the 4D12 epitope formed by Glu, Ser, or Val at P1 and the A-pocket was changed by the substitution of His for Tyr at residue 171 of HLA-B*3501 molecules. This was confirmed by testing the binding of mAb 4D12 to HLA-B*3501 mutant molecules at residue 171 carrying these peptides. These results together suggest that the conformation of the A-pocket and its hydrogen bound network with the P1 residue is also critical for the binding of mAb 4D12. The present study shows the molecular basis of the specificity of 4D12 for the peptide-HLA class I complex.

Original languageEnglish
Pages (from-to)149-158
Number of pages10
JournalImmunogenetics
Volume47
Issue number2
DOIs
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

HLA-B35 Antigen
HLA-B Antigens
Monoclonal Antibodies
Peptides
HLA-B5 antigen
Epitopes
Hydrogen

Keywords

  • Antibody
  • Epitope
  • HLA class I
  • Peptide

ASJC Scopus subject areas

  • Immunology
  • Genetics

Cite this

Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex. / Sakaguchi, Takashi; Takamiya, Yuji; Edidin, Michael; Nokihara, Kiyoshi; Miwa, Kiyoshi; Schönbach, Christian; Takiguchi, Masafumi.

In: Immunogenetics, Vol. 47, No. 2, 1998, p. 149-158.

Research output: Contribution to journalArticle

Sakaguchi, Takashi ; Takamiya, Yuji ; Edidin, Michael ; Nokihara, Kiyoshi ; Miwa, Kiyoshi ; Schönbach, Christian ; Takiguchi, Masafumi. / Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex. In: Immunogenetics. 1998 ; Vol. 47, No. 2. pp. 149-158.
@article{098a4728fb6344dc80caea1f628a0c63,
title = "Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex",
abstract = "The monoclonal antibody (mAb) 4D12 specific for the HLA-B5, -B35 cross-reacting group (CREG) bound to a fraction of HLA-B*3501 and HLA-B*5101 molecules carrying self-peptides. Analysis of the binding of mAb 4D12 to HLA-B*3501 and -B*5101 molecules pulsed with chemically synthesized peptides revealed that this mAb recognizes a restricted number of peptides and that P1 of the bound peptides critically influences its binding. The 4D12 mAb bound only to HLA-B*3501 molecules carrying peptides with Asn, Asp, Glu, Ser, and Val at P1. Analysis using an HLA-B*3501 crystallographic model suggested that 4D12 may recognize the side chain of the P1 residue that is pointing to the solvent. On the other hand, 4D12 bound only to HLA-B*51O1 molecules carrying peptides with Asn or Asp at P1, suggesting that the 4D12 epitope formed by Glu, Ser, or Val at P1 and the A-pocket was changed by the substitution of His for Tyr at residue 171 of HLA-B*3501 molecules. This was confirmed by testing the binding of mAb 4D12 to HLA-B*3501 mutant molecules at residue 171 carrying these peptides. These results together suggest that the conformation of the A-pocket and its hydrogen bound network with the P1 residue is also critical for the binding of mAb 4D12. The present study shows the molecular basis of the specificity of 4D12 for the peptide-HLA class I complex.",
keywords = "Antibody, Epitope, HLA class I, Peptide",
author = "Takashi Sakaguchi and Yuji Takamiya and Michael Edidin and Kiyoshi Nokihara and Kiyoshi Miwa and Christian Sch{\"o}nbach and Masafumi Takiguchi",
year = "1998",
doi = "10.1007/s002510050340",
language = "English",
volume = "47",
pages = "149--158",
journal = "Immunogenetics",
issn = "0093-7711",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex

AU - Sakaguchi, Takashi

AU - Takamiya, Yuji

AU - Edidin, Michael

AU - Nokihara, Kiyoshi

AU - Miwa, Kiyoshi

AU - Schönbach, Christian

AU - Takiguchi, Masafumi

PY - 1998

Y1 - 1998

N2 - The monoclonal antibody (mAb) 4D12 specific for the HLA-B5, -B35 cross-reacting group (CREG) bound to a fraction of HLA-B*3501 and HLA-B*5101 molecules carrying self-peptides. Analysis of the binding of mAb 4D12 to HLA-B*3501 and -B*5101 molecules pulsed with chemically synthesized peptides revealed that this mAb recognizes a restricted number of peptides and that P1 of the bound peptides critically influences its binding. The 4D12 mAb bound only to HLA-B*3501 molecules carrying peptides with Asn, Asp, Glu, Ser, and Val at P1. Analysis using an HLA-B*3501 crystallographic model suggested that 4D12 may recognize the side chain of the P1 residue that is pointing to the solvent. On the other hand, 4D12 bound only to HLA-B*51O1 molecules carrying peptides with Asn or Asp at P1, suggesting that the 4D12 epitope formed by Glu, Ser, or Val at P1 and the A-pocket was changed by the substitution of His for Tyr at residue 171 of HLA-B*3501 molecules. This was confirmed by testing the binding of mAb 4D12 to HLA-B*3501 mutant molecules at residue 171 carrying these peptides. These results together suggest that the conformation of the A-pocket and its hydrogen bound network with the P1 residue is also critical for the binding of mAb 4D12. The present study shows the molecular basis of the specificity of 4D12 for the peptide-HLA class I complex.

AB - The monoclonal antibody (mAb) 4D12 specific for the HLA-B5, -B35 cross-reacting group (CREG) bound to a fraction of HLA-B*3501 and HLA-B*5101 molecules carrying self-peptides. Analysis of the binding of mAb 4D12 to HLA-B*3501 and -B*5101 molecules pulsed with chemically synthesized peptides revealed that this mAb recognizes a restricted number of peptides and that P1 of the bound peptides critically influences its binding. The 4D12 mAb bound only to HLA-B*3501 molecules carrying peptides with Asn, Asp, Glu, Ser, and Val at P1. Analysis using an HLA-B*3501 crystallographic model suggested that 4D12 may recognize the side chain of the P1 residue that is pointing to the solvent. On the other hand, 4D12 bound only to HLA-B*51O1 molecules carrying peptides with Asn or Asp at P1, suggesting that the 4D12 epitope formed by Glu, Ser, or Val at P1 and the A-pocket was changed by the substitution of His for Tyr at residue 171 of HLA-B*3501 molecules. This was confirmed by testing the binding of mAb 4D12 to HLA-B*3501 mutant molecules at residue 171 carrying these peptides. These results together suggest that the conformation of the A-pocket and its hydrogen bound network with the P1 residue is also critical for the binding of mAb 4D12. The present study shows the molecular basis of the specificity of 4D12 for the peptide-HLA class I complex.

KW - Antibody

KW - Epitope

KW - HLA class I

KW - Peptide

UR - http://www.scopus.com/inward/record.url?scp=0031974925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031974925&partnerID=8YFLogxK

U2 - 10.1007/s002510050340

DO - 10.1007/s002510050340

M3 - Article

C2 - 9396861

AN - SCOPUS:0031974925

VL - 47

SP - 149

EP - 158

JO - Immunogenetics

JF - Immunogenetics

SN - 0093-7711

IS - 2

ER -